Success Metrics

Clinical Success Rate
100.0%

Based on 1 completed trials

Completion Rate
100%(1/1)
Active Trials
1(20%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
40%
Ph phase_3
1
20%

Phase Distribution

0

Early Stage

0

Mid Stage

1

Late Stage

Phase Distribution3 total trials
Phase 3Large-scale testing
1(33.3%)
N/ANon-phased studies
2(66.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

1 of 1 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(1)
Other(3)

Detailed Status

unknown3
Recruiting1
Completed1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 31 (33.3%)
N/A2 (66.7%)

Trials by Status

recruiting120%
unknown360%
completed120%

Recent Activity

1 active trials
Showing 5 of 5
recruiting

Identification of Phenotypic Factors That Predict Success for Weight Loss and Long-term Weight Maintenance

NCT02043457
unknown

Precision Medicine for Combined Hepatocellular-Cholangiocarcinoma

NCT06146127
unknownnot_applicable

Comparison on Blood Pressure Effect of an Equivalent Sodium Intake, With Different Nature, for Hypertensive Subjects

NCT05108402
unknownphase_3

Bedside Genetic or Pharmacodynamic Testing to Prevent Periprocedural Myonecrosis During PCI (ONSIDE TEST)

NCT01930773
completednot_applicable

Human Genomic Population Structure and Phenotype-genotype Variation in ADME Genes in Four Populations

NCT02789527

Clinical Trials (5)

Showing 5 of 5 trials
NCT02043457

Identification of Phenotypic Factors That Predict Success for Weight Loss and Long-term Weight Maintenance

Recruiting
NCT06146127

Precision Medicine for Combined Hepatocellular-Cholangiocarcinoma

Unknown
NCT05108402Not Applicable

Comparison on Blood Pressure Effect of an Equivalent Sodium Intake, With Different Nature, for Hypertensive Subjects

Unknown
NCT01930773Phase 3

Bedside Genetic or Pharmacodynamic Testing to Prevent Periprocedural Myonecrosis During PCI (ONSIDE TEST)

Unknown
NCT02789527Not Applicable

Human Genomic Population Structure and Phenotype-genotype Variation in ADME Genes in Four Populations

Completed

All 5 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
5